(named Ct) and (Nt+Ct) ± with both mutations ± nonphosphorylatable c-Jun mutants. In cooperation with Ras, the Ct mutant and wt c-Jun display similar oncogenic properties whereas the Nt form was defective in transforming REF cells. Unexpectedly, the Nt+Ct mutant exhibited identical oncogenic properties to wt cJun, demonstrating that the Ct mutation rescues in cis the Nt mutation. The transcriptional activity and the capacity to bind the c-Jun coactivator CREB Binding Protein (CBP) were enhanced by Ras for the wt and Ct proteins but not for the Nt mutant. Interestingly, the Nt+Ct mutant presents identical transactivation and CBP binding activities to wt c-Jun. Therefore the rescue in cis of the defective Nt mutation by the Ct mutation seems to be due to the recovery of CBP binding. Our results revealed that the process of oncogenic cooperation can occur between Ras and the Nt+Ct non-phosphorylatable c-Jun protein. Keywords: c-Jun transcription factor ± phosphorylation sites; rat embryo ®broblasts; CBP interaction; oncogene cooperation Although oncogenic cooperation has been described for almost twenty years (Rassoulzadegan et al., 1982; Land et al., 1983) very little is known about the molecular mechanisms underlying this process. Recently, activated Ha-Ras has been found to induce premature senescence in primary ®broblasts ± but not in established cell lines ± leading to a cell cycle arrest (Serrano et al., 1997) . This property could explain why Ras by itself is not transforming in these cells and requires the cooperation with a nuclear oncoprotein. The sequence-speci®c c-Jun transcription factor has been found to cooperate with the activated Ha-Ras oncogene to transform primary cultures of REF cells (Schutte et al., 1989) . The focus-formation capacity of c-Jun requires its N-terminal transactivating domain . Ras has been shown to stimulate phosphorylation of the c-Jun N-terminal residues Ser-63 and Ser-73, and these post-translational modi®cations in turn are necessary for regulated transactivation and oncogene cooperation . In addition to the N-terminal site, c-Jun proteins are also phosphorylated on serines and threonines in their C-terminal part. But in that case the phosphorylation has an inhibitory role on c-Jun DNA binding activity and transactivation (Boyle et al., 1991; Nikolakaki et al., 1993) .
To analyse the respective roles of phosphorylation sites of the mouse c-Jun gene in oncogenic cooperation, we tested the activities of the N-terminal c-Jun Ala 63/73 , named Nt, of the C-terminal c-Jun Ala 234/242/246/252 , named Ct, and of the (Nt+Ct) ± with both mutations ± non-phosphorylatable c-Jun mutants (Figure 1a ). Primary cultures of REF cells were transiently cotransfected with the dierent c-Jun constructs and Ras. Expression of the c-Jun proteins was analysed by Western blotting using anti-c-Jun antibodies ( Figure  1b) . Our results show that the c-Jun mutants are expressed equally to wt c-Jun, in the presence or absence of Ras cotransfection, and that the level of endogenous c-Jun protein is undetectable under our experimental conditions. We have also veri®ed the Nt phosphorylation mutants by blotting the same cellular extracts with anti-phospho-c-Jun antibodies, speci®c for phospho-Ser-63 and -73 of c-Jun. As expected, the Nt and Nt+Ct mutants were not detected by these antibodies. Furthermore, the phosphorylation of the N-terminal site was strongly augmented by Ras cotransfection in the case of the wt and Ct proteins (Figure 1b) .
In order to test the oncogenic potential of the dierent c-Jun mutants, we then performed focus formation assays by cotransfecting REF cells with , this diminution was systematically observed in ten independent experiments and is highly signi®cant with a calculated P53610
79
. It is important to notice that, in such experiments, intrinsic variations are often observed, essentially due to variability in serum batches. The experiments presented here were performed with the same batch of serum. Unexpectedly, the Nt+Ct mutant exhibited identical oncogenic properties to wt c-Jun (Figure 2a ). This result demonstrates that the defective transforming phenotype of Nt mutant can be completed in cis by mutation of the C-terminal site. In REF cells, identical data were obtained with the human c-Jun gene and its corresponding phosphorylation mutants (data not shown). Nt , the N-terminal phosphorylation site is mutated by substitution of serines 63 and 73 to alanines (MeÂ tivier et al., 1993) . In Jun Ct , the C-terminal phosphorylation site is mutated by substitution of serines 246 and 252 and threonines 234 and 242 to alanines (these amino acids correspond to the C-terminal threonines 231/239 and serines 243/249 in the human protein; Boyle et al., 1991; Lin et al., 1992) . The C-terminal Thr/Ser to Ala substitutions (Jun Ct ) were directly inserted into the mouse cjun sequence between the natural SapI and the arti®cial HindIII (covering lysine 260 and leucine 261; Vandel et al., 1995) restriction sites using two partially overlapping, double stranded mutated oligonucleotides. The Nt+Ct double mutant, designated Jun Nt+Ct , was generated by exchanging the N-terminal and Cterminal parts of c-jun at the unique internal AccI restriction site. The presence of the mutated alanines was con®rmed by DNA sequencing. The various sequences encoding c-Jun, c-Jun Nt , cJun Ct and c-Jun Nt+Ct were cloned into the pDP and pLMP expression vectors and used for transactivation and transformation assays, respectively (Vandel et al., 1996) In order to gain insight into the molecular mechanism involved in the oncogenic cooperation between Nt+Ct c-Jun and Ras, we then investigated the transactivating potential of the dierent constructs, in presence or absence of Ras. Transient cotransfections with a 56TRE-tk-Luc reporter construct in REF cells were performed. Transcriptional activities of wt cJun and Ct mutant were equally stimulated by Ras (Figure 2b ). This result is consistent with the capacity of Ras to enhance phosphorylation of the transactivating domain (Figure 1b) . As expected, the Nt mutant was unresponsive to Ras. Interestingly, as compared to wt and Ct, the Nt+Ct mutant displays the same strong response to Ras (Figure 2b) . These results strongly suggest that: (i) there is a strict correlation between the eect of Ras on the transactivation of the dierent cJun proteins and their oncogenic potential; (ii) Ras is capable to stimulate c-Jun transcription activity by a mechanism that does not require phosphorylation of the c-Jun transactivation domain.
Since c-Jun C-terminal phosphorylation aects c-Jun DNA binding (Boyle et al., 1991; Nikolakaki et al., 1993) , we performed a gel-shift analysis with protein extracts from REF cells transiently transfected with the dierent c-Jun mutants plus or minus Ras. Extracts were incubated with a radiolabeled consensus TRE oligonucleotide probe with or without wt cold TRE or mutated cold TRE oligonucleotides, used as competitors. After electrophoresis, non denaturing PAGE gels were scanned on a radio-imager and one representative gel is shown in Figure 3 . Consistent with the very low expression of endogenous c-Jun protein, the speci®c band-shift observed in mock-or Ras-transfected cells is barely detectable and migrates faster than c-Jun homodimer transfected proteins. This endogenous AP1 complex is probably composed of dierent partners than c-Jun. Noteworthy, this complex is more abundant in Ras transfected cells, which is in agreement with the Ras activation of the TREluciferase reporter (Figure 2b) . A speci®c band-shift is observed in REF cells transfected with the dierent cJun. In order to normalize and compare the amount of the various speci®c band-shifts, we analysed the levels of c-Jun protein expressed in the same extracts by Western blotting (data not shown). Corrected values are giving at the bottom of Figure 3 . No signi®cant variation was observed in the DNA binding activities of either wt or mutated c-Jun proteins. Moreover, Ras does not aect the DNA binding activity of the overexpressed c-Jun proteins. Therefore neither the defect of the Nt mutant nor the rescue of the Nt+Ct mutant can be explained by variation in their capacity to bind TRE sequences.
Because the Nt+Ct mutant response to Ras does not seem to take place via a regulation of c-Jun phosphorylation or DNA binding activity, we hypothesized that Ras stimulates a transcriptional coactivator associated to c-Jun. It is known that c-Jun binds the coactivator CREB Binding Protein (CBP, Arias et al., 1994) and this binding requires c-Jun phosphorylation transiently transfected with the dierent pDP-c-Jun constructs plus or minus Ras, and protein extracts were prepared as described in Figure 1b . Extracts were then dialyzed on Sephadex G50 columns against 20 mM HEPES pH 7.9, 120 mM KC1, 35% glycerol, 2 mM EDTA, 10 mM MgC1 2 and 2 mM DTT. Three mg of dialyzed proteins were pre-incubated with 2 mg of poly-d(I-C) and 2% CHAPS buer for 30 min at room temperature. 5610 4 c.p.m. of a 32 P radiolabeled TRE oligonucleotide probe was then added for another 30 min, in the presence or absence of either a cold wt TRE or a cold mutated TRE (mTRE) oligonucleotide as competitor, as indicated. Sequences of the oligonucleotides (5' to 3') were: AGCTAAAGTGGTGACTCATCACTAT for the wt TRE, and AGCTAAAGTGGTCTGTCATCACTAT for mTRE. Protein-DNA complexes were run on 6% non-denaturing PAGE gels. After drying, gels were analysed with the STORM radioimager. Protein extracts were analysed in parallel by Western blotting using antic-Jun antibodies, as described Figure 1b . Quanti®cation of the dierent c-Jun protein expression levels were used to normalize the values obtained for the dierent speci®c band-shifts. Arrows indicate the position of ectopic c-Jun and endogenous AP1 (Endo AP1) shifts. NS stands for non speci®c shift. One representative gel, out of two, is shown on serines 63 and 73 (Arias et al., 1994; Bannister et al., 1995) . We therefore tested the ability of the dierent c-Jun mutants to bind to CBP proteins. Primary REF cells were transiently transfected with the dierent constructs plus or minus Ras and CBP proteins were then immunoprecipitated from cell lysates. Co-immunoprecipitated proteins were separated by PAGE and analysed by Western blotting using anti-c-Jun antibodies (Figure 4, upper panel) . In parallel on the same protein extracts, we analysed by Western blotting the expression of endogenous CBP in the dierent conditions (Figure 4, lower panel) . This latter quanti®cation was used to normalize the amount of the transfected c-Jun proteins co-immunoprecipitated with CBP. Cotransfection with Ras induces a twofold increase in the amount of wt c-Jun or Ct mutant proteins bound to CBP. Conversely, the amount of Nt protein bound to CBP was two times lower than wt and was not signi®cantly enhanced by Ras. These results con®rm the essential role of c-Jun N-terminal phosphorylation in c-Jun/CBP interaction (Arias et al., 1994; Bannister et al., 1995) . Compared to the Nt protein, we observed in the Nt+Ct protein a strong binding to CBP, which was enhanced two times by Ras (Figure 4 ). This latter result strongly suggests that the impairment of c-Jun/CBP interaction due to the N-terminal mutation is compensated by the Cterminal mutation. One can hypothesize that the Cterminal mutation induces a conformational change in the c-Jun protein which reverses the inhibitory eect of the N-terminal mutation, rendering the protein responsive to Ras. Further work is necessary to try to characterize this putative conformational change in cJun protein and to understand its consequence on the c-Jun/CBP interaction.
Altogether our data demonstrate that mutation of the C-terminal c-Jun phosphorylation site is capable to complement in cis the N-terminal mutation. This complementation was observed in focus formation assays, in transactivation experiments and in CBP binding analysis. In each case, the complementation totally reverses the Nt phenotype towards the wt phenotype.
Finally, our results also revealed that Ras is capable of activating a non-phosphorylatable c-Jun protein. This eect could be due to the known stimulatory direct eect of Ras and/or activation of the MAP Kinase pathway on CBP activity (Nakajima et al., 1996; Liu et al., 1998) 
